We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.17B
1-Year Est. Return 92.19%
This Fund
S&P 500
This Quarter Est. Return
+15.02%
1 Year Est. Return
+92.19%
3 Year Est. Return
+240.57%
5 Year Est. Return
+377.11%
10 Year Est. Return
+3,179.38%
AUM
$3.99B
AUM Growth
+$445M
Cap. Flow
+$169M
Cap. Flow %
4.22%
Top 10 Hldgs %
26.88%
Holding
133
New
39
Increased
28
Reduced
23
Closed
37

Top Buys

Rank Stock Value
1
LBTYA icon
Liberty Global Class A
LBTYA
+$109M
2
MRVL icon
Marvell Technology
MRVL
+$99.1M
3
CSC
Computer Sciences
CSC
+$94.2M
4
UHS icon
Universal Health Services
UHS
+$82.5M
5
BABA icon
Alibaba
BABA
+$82.4M

Top Sells

Rank Stock Value
1
RRC icon
Range Resources
RRC
+$86.2M
2
CI icon
Cigna
CI
+$69.3M
3
CRM icon
Salesforce
CRM
+$63M
4
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$61.7M
5
BIIB icon
Biogen
BIIB
+$55.1M

Sector Composition

Rank Sector Weight
1 Healthcare 47.49%
2 Miscellaneous 14.03%
3 Technology 13.85%
4 Communication Services 6.67%
5 Energy 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRVL icon
1
Marvell Technology
MRVL
$201B
$129M 3.24%
8,479,622
+6,433,672
+314% +$99.1M
JAZZ icon
2
Jazz Pharmaceuticals
JAZZ
$16B
$125M 3.14%
864,276
-68,847
-7% -$8.97M
OEF icon
3
PUT
iShares S&P 100 ETF
OEF
$20.5B
$124M 3.1%
+421,900
New +$43.6M
LBTYA icon
4
Liberty Global Class A
LBTYA
$3.62B
$111M 2.77%
+3,089,161
New +$109M
BIIB icon
5
Biogen
BIIB
$32.6B
$107M 2.67%
390,664
-195,046
-33% -$55.1M
WFT
6
DELISTED
Weatherford International plc
WFT
$102M 2.55%
15,289,479
+7,404,913
+94% +$43.4M
CSC
7
DELISTED
Computer Sciences
CSC
$98M 2.45%
+1,420,281
New +$94.2M
MDCO
8
DELISTED
Medicines Co
MDCO
$90.5M 2.27%
1,850,635
-866,806
-32% -$39.5M
BABA icon
9
Alibaba
BABA
$281B
$87.3M 2.19%
+810,019
New +$82.4M
UHS icon
10
Universal Health Services
UHS
$10B
$86.9M 2.18%
+697,958
New +$82.5M
BMRN icon
11
BioMarin Pharmaceuticals
BMRN
$12.9B
$86.3M 2.16%
983,126
-74,433
-7% -$6.62M
HUM icon
12
Humana
HUM
$48.2B
$81.4M 2.04%
394,842
+43,051
+12% +$8.9M
SBUX icon
13
Starbucks
SBUX
$119B
$77.5M 1.94%
+1,327,769
New +$75.1M
XNTK icon
14
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.01B
$77.3M 1.94%
+1,114,600
New +$73.4M
PCRX icon
15
Pacira BioSciences
PCRX
$1.05B
$74.2M 1.86%
1,627,277
+466,302
+40% +$20.2M
ELV icon
16
Elevance Health
ELV
$88.4B
$72.8M 1.82%
440,126
-96,331
-18% -$15.3M
GDDY icon
17
GoDaddy
GDDY
$12.8B
$67.4M 1.69%
1,779,472
+1,492,510
+520% +$54.1M
KITE
18
DELISTED
Kite Pharma, Inc.
KITE
$66.4M 1.66%
845,393
-152,071
-15% -$9.4M
PTLA
19
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$66.3M 1.66%
1,692,510
+1,114,360
+193% +$35.5M
SLCA
20
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$64.8M 1.62%
1,350,636
+493,765
+58% +$26.4M
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
$64.1M 1.6%
1,006,472
-272,383
-21% -$16.6M
BAX icon
22
Baxter International
BAX
$13.4B
$60.3M 1.51%
+1,162,488
New +$57.2M
HRTX icon
23
Heron Therapeutics
HRTX
$65.3M
$59M 1.48%
3,932,730
+1,199,453
+44% +$16.6M
AERI
24
DELISTED
Aerie Pharmaceuticals
AERI
$58.6M 1.47%
1,293,129
-142,626
-10% -$6.36M
TFCFA
25
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$53.9M 1.35%
+1,663,321
New +$50.8M
1
2 3 4 5

Similar funds

JC
Jacobs & Co San Francisco, California $1.17B AUM 37.3% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $1.16B AUM 40% 1-Year Est. Return
HCP
Hiddenite Capital Partners New York $1.16B AUM 95.58% 1-Year Est. Return
EC
Estate Counselors Thiensville, Wisconsin $1.16B AUM 21.97% 1-Year Est. Return
M
MOTCO San Antonio, Texas $1.17B AUM 23.84% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
VFP
Verus Financial Partners Richmond, Virginia $1.17B AUM 15.91% 1-Year Est. Return

PFM Health Sciences's Q1 2017 Portfolio in Review

As of Q1 2017, PFM Health Sciences held 133 positions worth $3.99B, up 13% from $3.55B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

PFM Health Sciences deployed $169M of net new capital in Q1 2017, opening 39 new positions and adding to 28 existing holdings. Its largest new stake was Liberty Global Class A: 3,089,161 shares worth $111M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 47% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Cigna, an estimated $69.3M trimmed.

  • PFM Health Sciences's largest Q1 2017 buy was Liberty Global Class A: 3,089,161 shares worth $111M.
  • PFM Health Sciences added most to Marvell Technology in Q1 2017, an estimated $99.1M increase.
  • PFM Health Sciences's biggest Q1 2017 reduction was Cigna, cutting an estimated $69.3M.
  • PFM Health Sciences fully exited Range Resources in Q1 2017, selling an estimated $86.2M.
  • PFM Health Sciences's ten largest holdings make up 27% of its $3.99B portfolio in Q1 2017.
  • PFM Health Sciences opened 39 new positions and closed 37 in Q1 2017.
  • PFM Health Sciences's portfolio value rose 13% quarter-over-quarter to $3.99B.

Based on PFM Health Sciences's 13F filing for Q1 2017, filed 15 May 2017.